Skip to content Skip to footer
Insights+ Key Biosimilars Events of February 2020
Insights+ Key Biosimilars Events of February 2020
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency Biosimilars are expected to be a cost-effective alternative to high-priced branded biologics, offering significant and much-needed cost savings to both payers and patients The Korean firm, Celltrion's Remsima also showed some updates in fields of approval and…
Dream Big for Your Personal and Business Growth
Q ed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium loremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. …
Graphic Design Principles
Q ed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium loremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. …
The Most Successful Ones Go Over the Top
Q ed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium loremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. …
Ads and Commercial in 2021
Q ed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium loremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. …
Viewpoint_Dr. Terri Phillips_2020
PharmaShots Interview: Merz Aesthetics’ Dr. Terri Phillips Shares Insight on GP Campaign for Xeomin
In an interview with PharmaShots, Dr. Terri Phillips, Chief Medical Affairs Officer at Merz Aesthetics shared her views on the new campaign with Gwyneth Paltrow for its flagship product Xeomin. She also shed light on Medical Aesthetic treatments during the pandemic and how Merz is working to meet the demand. Shots: Merz Aesthetics collaborates with Gwyneth Paltrow for the launch of the company's first…

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]